Actinic Keratosis Treatment Market Promising Growth Opportunities over 2018-2028 | Sun Pharmaceutical Ltd., Bausch Health Companies Inc., Almirall, LLC, LEO Pharma Inc

Top two brands of Photo Dynamic Therapy account for maximum revenue share in the actinic keratosis treatment market

Photodynamic therapy (PDT) is said to be one of the most successful treatment options for actinic keratosis treatment. PDT is mostly been prescribed by the physicians when the topical treatment or Cryotherapy fails. Aminolevulinic acid is applied as a medication on the infected part of the skin during photodynamic therapy for actinic keratosis treatment, which is then activated with a blue light, or intense pulsed light source. Currently, Levulan Kerastick by Sun Pharmaceutical, Ameluz by Biofrontera and Metvix by Galderma are the major products available in the market for photodynamic therapy in actinic keratosis treatment. These brands of photodynamic therapy for actinic keratosis treatment are estimated to gain majority of the market share. The actinic keratosis treatment market is consolidated in nature for PDT products.

Large number of products in the pipeline for actinic keratosis treatment throughout the forecast period

Various topical medication options are available for actinic keratosis treatment, which has given the dermatologists an upper hand to prescribe appropriate customized patient treatment options. There are currently 39 studies in phase 4 for the actinic keratosis treatment in the U.S. FDA, discussing potential drugs/ combinations/upgradation, etc. to be launched in future. For instance, Aclaris Therapeutics, Inc. is focusing on to approve 101-A solution for the actinic keratosis treatment (currently in phase 4), which is a topical treatment option. Various new product launches are expected in near future though large number of product are in pipeline for actinic keratosis treatment, which will increase competition among product manufacturers in the actinic keratosis treatment market.

Awareness programs by non-profit organizations to fuel sales of actinic keratosis treatment products

Non-profit organizations are conducting awareness programs to spread awareness among the general people regarding the methods of actinic keratosis treatment. The Skin Cancer Foundation has launched an awareness program named “Rays Awareness - Preventing Skin Cancer”, which explains the effect of UV radiation of sun and tanning beds, and their affects on the skin. This seminar also highlights the comparison of option for actinic keratosis treatment. In similar manner, the British Association of Dermatologist also circulated a leaflet that explains the causes of actinic keratosis and their adverse effects. The leaflet also had information about the options available for actinic keratosis treatment. Such programs have increased the awareness level among people about the actinic keratosis treatment in developed economies, which is consequently expected to increase the adoption for actinic keratosis treatment.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3233

Lack of skilled medical professionals and low penetration of treatment in developing economies may deter the growth of the actinic keratosis treatment market

The actinic keratosis treatment by photodynamic therapy, cryotherapy or chemical peel requires skilled plastic surgeons. According to the WHO, shortage of 12.9 million healthcare workers by 2035 is expected across the globe. The demand for plastic surgery has increased in throughout the globe since the last decade, but the number of plastic surgeons has declined. Besides, the treatment-seeking rate of actinic keratosis is relatively low in developing countries. Also, the awareness regarding the actinic keratosis treatment in these economies is also low. On the other hand, the cost of photodynamic therapy for actinic keratosis treatment is high in these economies. This factors may lead to sluggish growth of actinic keratosis treatment market.

Competitive Landscape

Competition section of the actinic keratosis treatment market features profiles of key players operating in the industry based on their market shares, differential strategies, product offerings, marketing approach. Some of the key players featured in this report include GlaxoSmithKline plc., Novartis AG, Nestle SA, Sun Pharmaceutical Ltd., Bausch Health Companies Inc., Almirall, LLC, LEO Pharma Inc., Pierre Fabre Pharmaceuticals, Inc., Biofrontera, Cipher Pharmaceuticals Inc. Tier 1 players of actinic keratosis treatment market are estimated to gain 32.1% market value share and accounts for market value of US$ 689.3 Mn in 2017. Inorganic growth routes followed by product manufacturers of actinic keratosis treatment market to boost revenues. Collaborative product manufacturing agreements among manufacturer of actinic keratosis treatment market also boosting incremental innovation and thus endpoint efficacy in actinic keratosis treatment.

Definition

An actinic keratosis (AK), also known as a solar keratosis, is a crusty, scaly growth caused by damage from exposure to ultraviolet (UV) radiation. Actinic keratosis is considered a precancer because if left alone, it could develop into a skin cancer, most often the second most common form of the disease, squamous cell carcinoma (SCC). ~ The Skin Cancer Foundation

Need more information about Report methodology ? @ https://www.futuremarketinsights.com/askus/rep-gb-3233

About the Report

FMI conducted a research study on actinic keratosis treatment market for the forecast period 2018 to 2028. The actinic keratosis treatment market report offers a comprehensive evaluation of the business opportunities prevailing in the actinic keratosis treatment market along with insights on prevalence treatment seeking rate in top countries, combination the therapy prescribes by the dermatologist for actinic keratosis treatment, cost of different actinic keratosis treatment options by region, key regulatory and reimbursement scenario. . The report on actinic keratosis treatment also elaborates on the macroeconomic factors influencing the dynamics of actinic keratosis treatment market and its futuristic potential.

Segmentation

The report offers a comprehensive taxonomy of actinic keratosis treatment market based on treatment type, disease type, end user and region. Different treatment option are available for actinic keratosis treatment which includes topical treatment, procedure modality and photodynamic therap. All this options for actinic keratosis treatment taken into consideration while estimating and forecasting the market value for actinic keratosis treatment. Both clinical actinic keratosis and subclinical actinic keratosis is included in disease type segment of the report. The global actinic keratosis treatment market report also includes the end user segment which covers the hospitals, private dermatology clinics, laser therapy centers, cancer treatment centers, spas and rejuvenation centers, homecare. The actinic keratosis treatment market has been analyzed across regions of North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan and MEA.

Report Press Release: https://www.futuremarketinsights.com/press-release/actinic-keratosis-treatment-market

Additional Questions Answered

Some of the additional questions addressed in this report on actinic keratosis treatment market-

What is the revenue potential of photodynamic therapy across regions of North America and Europe?

Who are the key competitors of actinic keratosis treatment and what are their product portfolio and growth hacking strategy?

What are major factors influencing the growth of actinic keratosis treatment?

Which are the trend followed by the leading manufacturer to retain their market share?

What is prevalence and treatment seeking rate for actinic keratosis treatment in top countries?

Research Methodology

The actinic keratosis treatment market has been estimated based on supply-demand approach.  Firstly the prevalence and treatment seeking rate of actinic keratosis is estimated for top 20 countries to estimate the patient pool adopting the actinic keratosis treatment. After that cost of different actinic keratosis treatment option is analyzed to estimate the market value for actinic keratosis treatment. This information is further validated with rigorous primary research (including interviews, surveys, in-person interactions, and viewpoints of seasoned analysts) and secondary research (including verified paid sources, authentic trade journals, and resourceful databases). The research study on actinic keratosis treatment market also includes top trends and macro as well as micro economic factors shaping the actinic keratosis treatment market. With this approach, the report on actinic keratosis treatment market anticipates the industry attractiveness of every major segment in actinic keratosis treatment market over the forecast period.

About Us

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Contact Us

U.S. Office

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

Email: sales@futuremarketinsights.com

Web: https://www.futuremarketinsights.com/

This release was published on openPR.